RBQMLive, Sponsored by CluePoints, Wins Prestigious Sales and Marketing Award
How to Leverage Machine Learning & Deep Learning for Natural Language Processing in Clinical Trials
Expert Speaker Lineup Revealed for Award Winning RBQM Event
CluePoints, Ken Getz & Tufts CSDD and PwC Unveil New RBQM Insights Report at DIA Global Annual Meeting 2023
How to Leverage AI for High-Quality Clinical Trials
Enhancing RBQM with Artificial Intelligence: Your Questions Answered
CluePoints Supports Launch of RBQM Live 2023 as Premier Event Sponsor
CluePoints Announces Amit Patel as New CFO
Events
Find out where we’re headed next.
Featured Whitepaper
ICH E6 (R2)
Summary
Paper
Created in conjunction with our peers at TUFTS Center for the Study of Drug Development, this paper provides insights on how companies are responding to ICH E6 (R2) and information on the key themes on adoption.
Featured Webinar
ICH E6 (R2)
Webinar
Series
This recorded webinar covers all of the frequently asked Questions about ICH E6 (R2), Risk-Based Study Execution (RBx) and what’s required from a people, process & technology standpoint.